Performance and training recovery are among the most common reasons people explore doctor-led health protocols. Here is what the research has examined, what it actually shows, and what the important distinction between therapeutic use and doping looks like.
This article is for general educational purposes only and does not constitute medical advice. Doctor-led health protocols in Australia require assessment and prescription from an AHPRA-registered medical practitioner. Competitive athletes should check the status of any compound with their sport's governing body before use. Always consult a qualified doctor before making any decisions about your health.
Performance and training recovery are among the most common reasons people explore doctor-led health protocols. The connection makes sense at a biological level. Many of the processes that determine training adaptation and recovery - growth hormone secretion, protein synthesis, tissue repair, inflammation regulation, and sleep quality - are areas where scientific research has been active. Understanding what the research actually examines, and being clear about the distinction between therapeutic use and performance enhancement in a competitive sport context, matters for anyone exploring this area.
This guide covers the biological processes relevant to training adaptation, the research areas that have been studied in performance and training contexts, what the evidence shows, and the important distinction between doctor-supervised therapeutic use and use that is banned in competitive sport.
Training adaptation depends on a cascade of biological processes. Growth hormone secretion, predominantly during deep sleep, drives protein synthesis and tissue repair. Inflammatory signalling initiated by training triggers the repair and adaptation processes that make muscles stronger and more resilient. The quality of sleep determines whether the hormonal and repair processes that training triggers actually complete properly.
When any of these processes is compromised, training adaptation slows and injury risk increases. Older athletes experience this more acutely because growth hormone declines with age, sleep quality often deteriorates, and tissue repair capacity reduces. This is the biological context within which research into performance-relevant pathways is typically considered.
Scientific research into performance and training biology covers a range of pathways. The following areas represent fields of active investigation. The maturity and scope of the published literature varies between them, and the specific compounds appropriate for any individual are determined solely by a prescribing doctor following clinical assessment.
Growth hormone plays a central role in tissue repair, body composition, and recovery. Research has examined compounds that interact with growth hormone signalling pathways and the downstream effects on tissue repair and recovery processes. Blood monitoring is a feature of research protocols in this area given the interaction of these pathways with downstream hormonal markers.
Faster and more complete recovery between training sessions is central to long-term training adaptation. Research has examined compounds that interact with tissue repair signalling across various tissue types. This area has one of the more extensive preclinical research bases relevant to training biology, with studies examining interaction with growth factor signalling and the local tissue environment during repair.
Mitochondrial function is central to endurance performance and metabolic efficiency. Research into mitochondria-derived compounds and their interaction with metabolic regulation and cellular energy pathways has attracted attention in performance biology contexts. The published human clinical evidence in this area is at an earlier stage than some other pathways.
The relationship between growth hormone pathways and body composition has been examined in clinical research settings including regulatory approval contexts in some countries for specific applications. Research in this area has examined interaction with growth hormone output and body composition markers including visceral fat and lean tissue.
This is an area where being completely clear matters. Several compounds studied in performance biology contexts appear on the World Anti-Doping Agency prohibited list and are banned in competitive sport. This means competitive athletes subject to anti-doping regulations cannot use these compounds regardless of whether they are accessed through a legitimate prescription.
This is distinct from their legal status for non-competitive therapeutic use. Being banned in sport does not make a compound illegal for general medical use - in the same way that many prescription medicines are banned in sport but are routinely prescribed and used by non-athletes. A recreational exerciser or non-competitive athlete using these compounds through a legitimate prescription from an AHPRA-registered doctor is doing something legal. A competitive athlete using the same compounds while subject to anti-doping rules is not.
If you are a competitive athlete: Check the WADA prohibited list and your sport's specific anti-doping regulations before using any compound, whether prescribed or otherwise. Some compounds available through doctor-led protocols are on the prohibited list. A legitimate prescription does not exempt you from anti-doping obligations in competitive sport. If you are unsure about a specific compound, consult your sport's governing body or the Sports Integrity Australia online query system before proceeding.
The honest position on compounded medicines and performance is that the mechanisms are biologically plausible and the preclinical evidence base is substantial for several pathways, but the specific human performance evidence is less developed than is sometimes implied in online discussions. Growth hormone's role in tissue repair, body composition, and recovery is well established. Whether compounds that influence growth hormone output produce meaningful performance benefits in already-healthy, well-trained individuals is less clearly established in human clinical research than in animal models.
The clearest biological rationale tends to be for older athletes, people recovering from injury, or individuals whose training adaptation has plateaued in ways that may relate to declining growth hormone, reduced recovery capacity, or suboptimal sleep. In these contexts the biological rationale is strongest and the potential relevance most clearly matches what the research has examined.
Where clinically appropriate, individuals may undergo an assessment by an AHPRA-registered medical practitioner. Any decision regarding treatment is made solely by the prescribing doctor following an assessment of the individual's medical history, training context, recovery challenges, and clinical circumstances. The specific compounds included in any protocol are decided entirely by the prescribing doctor based on that assessment. There is no cost to request an assessment, and no obligation to proceed.
Start with a free assessment. A doctor reviews your health history and determines whether a protocol is clinically appropriate for your specific situation. No cost until you choose to proceed.